CE, MOC & Certificates

With a focus on multidisciplinary care, this Symposium will highlight cutting-edge strategies and innovations in gastrointestinal cancer care and research with valuable perspectives from the international experts on the faculty and planning committees. Focusing on the theme of Local Practice, Global Outcomes, the Symposium will feature education and science sessions on worldwide perspectives in different disease sites and subspecialties. Discover emerging data and novel research through abstracts showcased in Oral Abstract Sessions, new Rapid Fire Abstract Sessions, and Poster Sessions with networking events.

Available Certificates

Attendees can log in to the iPlanner or CE Portal to access any of the following certificates after noting their participation:

  • Continuing Medical Education Certificate – available for physicians who would like to receive CME credits for their participation at the Symposium
  • Certificate of Participation – all other attendees may request a Certificate of Participation after recording their session participation. Please note that all final decisions regarding certificate acceptance toward any licensure requirements will be made by the licensing organization to which the certificate is submitted.
  • Certificate of Attendance – Attendees can download a Certificate of Attendance from the Attendee Resource Center if they need a record of their attendance at the Symposium but do not require documentation for continuing education purposes. Please note that this certificate does not award any continuing education credits.

For instructions on how to claim credit and access certificates, please see the ‘Symposium Feedback and Credit Claim Instructions section.

Symposium Feedback and Credit Claim Instructions

Every participant is encouraged to submit a Symposium Feedback Form, provide session ratings, and access certificates for the Symposium through the iPlanner app or CE Portal. Your feedback is utilized by leadership to enhance programs, develop new initiatives, gauge educational impact, and plan for future meetings. 

  • To provide feedback on a specific session
  1. Download the iPlanner app
  2. Select a session by searching by time or track
  3. Select “Rate This Session” to submit feedback on each session you attend
  • To access certificates and claim credit
  1. Log into the CE Portal using your ASCO.org username and password
  2. Select the appropriate meeting and your role
  3. Select “CME Certificate” to claim credit and download the certificate
  • To give overall feedback on the meeting
  1. Log in to the CE Portal using your ASCO.org username and password
  2. Select “Provide Meeting Feedback” to submit your feedback on the symposium

To receive ABIM MOC points, participants must submit their Symposium Feedback Form and claim their CME credits in the CE Portal for the Symposium by February 22, 2018. Once both of these steps are complete, ASCO will transmit all information to ABIM on the participant’s behalf.

Accreditation and Designation Statement

In support of improving patient care, the American Society of Clinical Oncology is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

AMA Credit Designation Statement - Physicians

The American Society of Clinical Oncology designates this live activity for a maximum of 20.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AAPA/NCCPA Credit Designation Statement – PAs

PAs may claim a maximum of  20.75 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™from organizations accredited by ACCME or a recognized state medical society.

All non-physician attendees are welcome to submit a request for a Certificate of Participation, which may enable non-physicians to apply their meeting participation toward re-licensure. Please note, however, that all final decisions regarding certificate acceptance will be made by the licensing organization to which the certificate is submitted.

Target Audience

This symposium is designed for physicians and researchers interested in the prevention, screening, evaluation, and management of gastrointestinal cancers, including, but not limited to medical, surgical, and radiation oncologists; pathologists; radiologists; and other translational-oriented laboratory scientists.

This symposium may also benefit nurses, pharmacists, physician assistants, and other health care professionals involved in clinical cancer care and cancer research.

Educational Needs Statement

The 2018 Gastrointestinal Cancers Symposium – Multidisciplinary Care: Local Practice, Global Outcomes gives healthcare providers across multiple disciplines and professions the opportunity to receive critical updates and recommendations to improve the care of patients with these cancers. Although incidence and mortality rates continue to increase, emerging science offers new options for multidisciplinary precision care through new and emerging diagnostic approaches, as well as innovative therapy options. Continued evolution in the clinical evidence base highlights the ongoing need for education in this area to ensure that all members of the cancer care team stay current on emerging therapies and diagnostic technologies. 

This program is also designed to provide opportunities for learners to interact with expert faculty of varying disciplines in both the sessions and in active networking events. These dialogues further equip health care providers to deliver optimal care for their patients diagnosed with gastrointestinal cancers.

Learning Objectives

Upon participation in this activity, attendees will be better able to

  • Collaborate across different specialties and with all members of the oncology care team to provide effective and patient-centered treatment and supportive care for patients with gastrointestinal cancers;
  • Examine the impact of healthcare disparities and differences in treatment standards across different global regions on the outcomes of patients with gastrointestinal cancers;
  • Consider the benefits and current challenges of implementing multimodality therapy for patients with cholangiocarcinoma, to include accurate identification of subtypes as well as optimal treatment sequencing;
  • Compare and contrast the disease characteristics that indicate different surgical options, as well as those that indicate that watchful waiting, to determine the best approach based on current evidence in the treatment of each patient with gastrointestinal cancers;
  • Review where certain diagnostic strategies can help to inform a more precise treatment of patients with gastrointestinal cancers based on current evidence, including testing for genetic syndromes, molecular characterization of tumors, and the use of novel imaging techniques
  • Outline recommended approaches for less common presentations of gastrointestinal cancers in patients, including early-onset colorectal cancer and rare tumors of the abdomen.

Disclaimer and Unlabeled Usage Statement

The information presented is that of the contributing faculty and presenters and does not necessarily represent the views of the Symposium Cosponsors and/or any named company or organization providing financial support. Specific therapies discussed may not be approved and/or specified for use as indicated by the faculty or presenters.  Therefore, before presenting any medication, please review the complete prescribing information including indications, contraindications, warnings, precautions, and adverse effects.

Commercial Supporters

ASCO and Conquer Cancer gratefully awknowledge the following companies for their support of the 2018 Gastrointestinal Cancers Symposium:

AstraZeneca Celgene Genentech
Ipsen Lilly Novartis
Pfizer Oncology Shire Taiho Oncology